chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry eye, Dry mouth, Thrombosis
Clinical narrative: blood clots on the outside of my legs and torso; dry mouth; dry eyes; This is a spontaneous report from a contactable consumer (patient). An 86-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration on 04Feb2021 (at the age of 86 years) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiry date unknown), via an unspecified route of administration, administered on an unspecified date in Jan2021 (at the age of 86 years) as dose 1, single for COVID-19 immunization. It was reported that the patient had the second (dose) Pfizer Covid shot on 04Feb2021, the next week on an unknown date in Feb2021, she got dry mouth, dry eyes and then I got little blood clots on the outside of my legs and torso." The patient did not receive any treatment for the events. The outcome of events was unknown.  The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hyperhidrosis, Seizure like phenomena, Syncope, Tremor
Clinical narrative: Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details:  One minute after the administration of the vaccine, patient started shaking and complaining of lightheadedness and dizziness. Patient was lied flat on the exam table with legs elevated. She has loose clothe on. These symptoms lasted about 2 minutes. Patient was provided with crackers and juice. She was monitored supervised for 30 minutes. Patient was discharged home with sister and advised to follow up with PCP.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling cold, Tremor
Clinical narrative: Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details:  One minute after the administration of the vaccine, patient started shaking and complaining of lightheadedness and dizziness. Patient was lied flat on the exam table with legs elevated. She has loose clothe on. These symptoms lasted about 2 minutes. Patient was provided with crackers and juice. She was monitored supervised for 30 minutes. Patient was discharged home with sister and advised to follow up with PCP.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: RUNNY NOSE; FEELING COLD; TIRED; This spontaneous report received from a health care professional concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 infection, and concurrent conditions included: no smoker, and other pre-existing medical conditions included: The patient had no history of using any immunomodulatory or immunosuppressive medication or anti inflammatory drugs. The patient did not have any adverse event after any previous vaccination, no history of hospitalization in last 30 days, with cause, no Illness at the time of vaccination. The patient was not pregnant and was not breastfeeding at time of vaccination. The patient had no other suspected causes including co-administered vaccine(s)/risk factors. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, expiry: UNKNOWN) .5 ml, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced runny nose, feeling cold, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from runny nose, feeling cold, and tired. This report was non-serious. This case, from the same reporter is linked to 20210846435, 20210846822 and 20210846649.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling cold, Rhinorrhoea
Clinical narrative: RUNNY NOSE; FEELING COLD; TIRED; This spontaneous report received from a health care professional concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 infection, and concurrent conditions included: no smoker, and other pre-existing medical conditions included: The patient had no history of using any immunomodulatory or immunosuppressive medication or anti inflammatory drugs. The patient did not have any adverse event after any previous vaccination, no history of hospitalization in last 30 days, with cause, no Illness at the time of vaccination. The patient was not pregnant and was not breastfeeding at time of vaccination. The patient had no other suspected causes including co-administered vaccine(s)/risk factors. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, expiry: UNKNOWN) .5 ml, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced runny nose, feeling cold, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from runny nose, feeling cold, and tired. This report was non-serious. This case, from the same reporter is linked to 20210846435, 20210846822 and 20210846649.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chest pain, Fatigue, Hypoaesthesia, Paraesthesia
Clinical narrative: left arm became tingly; left arm numb; listless; began to swell 13 minutes after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28May2021 08:30 (Lot Number: EW0183) (at age of 61-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at age of 61-year-old at left arm for covid-19 immunization. Patient was not pregnant. There was known allergies. No covid prior vaccination, no covid tested post vaccination. Medical history included IBS-D, Fibromyalgia, Sciatic Nerve Nerve, degenerative Joint Disease, TMJ Syndrome. There were no concomitant medications. No other vaccine in four weeks. The patient experienced left arm became tingly, numb, listless and began to swell 13 minutes after the vaccine. Events onset date was reported as 28May2021 08:30 AM. AEs resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), hospitalization for 3 days. Patient received treatment for the adverse events. The outcome of events was not recovered.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling
Clinical narrative: left arm became tingly; left arm numb; listless; began to swell 13 minutes after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28May2021 08:30 (Lot Number: EW0183) (at age of 61-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at age of 61-year-old at left arm for covid-19 immunization. Patient was not pregnant. There was known allergies. No covid prior vaccination, no covid tested post vaccination. Medical history included IBS-D, Fibromyalgia, Sciatic Nerve Nerve, degenerative Joint Disease, TMJ Syndrome. There were no concomitant medications. No other vaccine in four weeks. The patient experienced left arm became tingly, numb, listless and began to swell 13 minutes after the vaccine. Events onset date was reported as 28May2021 08:30 AM. AEs resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), hospitalization for 3 days. Patient received treatment for the adverse events. The outcome of events was not recovered.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Listless, Paraesthesia, Peripheral swelling
Clinical narrative: left arm became tingly; left arm numb; listless; began to swell 13 minutes after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28May2021 08:30 (Lot Number: EW0183) (at age of 61-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at age of 61-year-old at left arm for covid-19 immunization. Patient was not pregnant. There was known allergies. No covid prior vaccination, no covid tested post vaccination. Medical history included IBS-D, Fibromyalgia, Sciatic Nerve Nerve, degenerative Joint Disease, TMJ Syndrome. There were no concomitant medications. No other vaccine in four weeks. The patient experienced left arm became tingly, numb, listless and began to swell 13 minutes after the vaccine. Events onset date was reported as 28May2021 08:30 AM. AEs resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), hospitalization for 3 days. Patient received treatment for the adverse events. The outcome of events was not recovered.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Decreased appetite, Malaise
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary normal, Asthenia, Blood creatinine increased, Blood gases normal, Blood lactate dehydrogenase increased
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid, Blood potassium normal, Blood sodium normal, Blood urea increased, Body temperature increased
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, Chest X-ray abnormal, Diarrhoea
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Glomerular filtration rate decreased, Hypotension, Liver function test normal
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Neutrophil count decreased, Oxygen saturation decreased, Pneumonia, Procalcitonin
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased, Vomiting, White blood cell count increased
Clinical narrative: This is a 83y.o. female with medical history of HTN and DM II with insulin, lives at home. She presents in ED for shortness of breath and generalized weakness for 3 days. Very poor historian. Her SaO2 dropped to 82% at home in room air , increased to 90% with Non rebreathe mask when EMS came.  She also reports slight nauseas, vomiting and diarrhea, no bloody emesis. She denies chest pain , LOC or recent fall. No home oxygen. She received 2 dose of COVID vaccine .   ED course: arrive ED with Non Rebreather and SaO2 90%. Temp 103F, HR 104, hypotensive, BNP 166, covid detected, procal 1.56, CRP 48.8, LDH 353, lactic 3.1, D dimer > 10000, Troponin 0.15----0.27, sodium 140, K 3.7, BUN 25, Cr. 1.18, GFR 43, liver function panel WNL, VBG no acute concerns, WBC 14.2, Neutrophils 11.7, CXR consistent with pneumonia. CTA chest no PE. Decadron inj 6mg, admit in patient for further evaluation and management, ID consult
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Asthenia, Atelectasis, Blood culture negative, Blood test abnormal
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Culture urine negative, Death, Decreased appetite
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Haematemesis, Hypotension, Intensive care, Lethargy
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Lower urinary tract symptoms, Malaise, Oxygen saturation decreased, Pollakiuria, Resuscitation
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal tenderness, Agitation, Asthenia, Blood gases, Blood lactic acid normal
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, Decreased appetite, Depressed level of consciousness, Haemoglobin decreased
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hyperdynamic left ventricle, Hypotension, Intensive care, Lethargy, Oxygen saturation decreased
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pollakiuria, Pulse absent, SARS-CoV-2 test positive, Ultrasound Doppler abnormal, Urinary tract infection
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15.  Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: Vaccination administered, and patient was observed after 15 minutes for reaction.  Felt lightheaded and diaphoretic 15 minutes after vaccine administration- did not lose consciousness; thinks it is anxiety related.  Complete resolution of symptoms with supine positioning with slow elevation of head of bed over 15 minutes.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Hyperhidrosis
Clinical narrative: Vaccination administered, and patient was observed after 15 minutes for reaction.  Felt lightheaded and diaphoretic 15 minutes after vaccine administration- did not lose consciousness; thinks it is anxiety related.  Complete resolution of symptoms with supine positioning with slow elevation of head of bed over 15 minutes.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Cough, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Came to ER c/o abd pain for 3 days.  D/C home.  Came back 7/16/21 with difficulty breathing and cough.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Chest X-ray, Cough, Dyspnoea
Clinical narrative: Came to ER c/o abd pain for 3 days.  D/C home.  Came back 7/16/21 with difficulty breathing and cough.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Came to ER c/o abd pain for 3 days.  D/C home.  Came back 7/16/21 with difficulty breathing and cough.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Cough, Diarrhoea, Nausea, Pyrexia
Clinical narrative: Pt came to ER for fever, cough, and general weakness.  Onset 3 days prior.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: Pt came to ER for fever, cough, and general weakness.  Onset 3 days prior.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray, Cough, Pyrexia
Clinical narrative: Pt came to ER for fever, cough, and general weakness.  Onset 3 days prior.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pt came to ER for fever, cough, and general weakness.  Onset 3 days prior.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Diarrhoea, Haematochezia, Headache
Clinical narrative: BLOOD IN STOOL; SHAKINESS; URINARY TRACT INFECTION (UTI) SYMPTOMS SUCH AS SEDIMENT IN URINE; BRAIN FOG; NECK PAIN; INJECTION SITE REACTION; DIARRHEA; ARMS FEEL HEAVY; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned an adult female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid in JAN-2021. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 26-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On unspecified date in 01-JUL-2021, patient had COVID-19 antibody test, and it was positive 86.9 and patient was wondered why she was being mandated to get the vaccine. On 26-AUG-2021, the patient experienced blood in stool, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), shakiness, brain fog, neck pain, injection site reaction, diarrhea, arms feel heavy, headache, and fatigued. On an unspecified date in AUG-2021, The patient went to the hospital for evaluation due to the bloody stool and kidney pain, and had computerised tomogram (CAT) scan done. The patient reported that as per health care provider (HCP), the CAT scan was clear and it was from the shot.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness, blood in stool, diarrhea, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), neck pain, headache, brain fog, injection site reaction, fatigued, and arms feel heavy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210858571-Covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pyrexia, Renal pain, Urinary sediment present
Clinical narrative: BLOOD IN STOOL; SHAKINESS; URINARY TRACT INFECTION (UTI) SYMPTOMS SUCH AS SEDIMENT IN URINE; BRAIN FOG; NECK PAIN; INJECTION SITE REACTION; DIARRHEA; ARMS FEEL HEAVY; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned an adult female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid in JAN-2021. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 26-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On unspecified date in 01-JUL-2021, patient had COVID-19 antibody test, and it was positive 86.9 and patient was wondered why she was being mandated to get the vaccine. On 26-AUG-2021, the patient experienced blood in stool, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), shakiness, brain fog, neck pain, injection site reaction, diarrhea, arms feel heavy, headache, and fatigued. On an unspecified date in AUG-2021, The patient went to the hospital for evaluation due to the bloody stool and kidney pain, and had computerised tomogram (CAT) scan done. The patient reported that as per health care provider (HCP), the CAT scan was clear and it was from the shot.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness, blood in stool, diarrhea, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), neck pain, headache, brain fog, injection site reaction, fatigued, and arms feel heavy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210858571-Covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Diarrhoea, Fatigue, Feeling abnormal, Haematochezia
Clinical narrative: BLOOD IN STOOL; SHAKINESS; URINARY TRACT INFECTION (UTI) SYMPTOMS SUCH AS SEDIMENT IN URINE; BRAIN FOG; NECK PAIN; INJECTION SITE REACTION; DIARRHEA; ARMS FEEL HEAVY; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned an adult female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid in JAN-2021. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 26-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On unspecified date in 01-JUL-2021, patient had COVID-19 antibody test, and it was positive 86.9 and patient was wondered why she was being mandated to get the vaccine. On 26-AUG-2021, the patient experienced blood in stool, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), shakiness, brain fog, neck pain, injection site reaction, diarrhea, arms feel heavy, headache, and fatigued. On an unspecified date in AUG-2021, The patient went to the hospital for evaluation due to the bloody stool and kidney pain, and had computerised tomogram (CAT) scan done. The patient reported that as per health care provider (HCP), the CAT scan was clear and it was from the shot.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness, blood in stool, diarrhea, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), neck pain, headache, brain fog, injection site reaction, fatigued, and arms feel heavy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210858571-Covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site reaction, Limb discomfort, Neck pain, SARS-CoV-2 antibody test
Clinical narrative: BLOOD IN STOOL; SHAKINESS; URINARY TRACT INFECTION (UTI) SYMPTOMS SUCH AS SEDIMENT IN URINE; BRAIN FOG; NECK PAIN; INJECTION SITE REACTION; DIARRHEA; ARMS FEEL HEAVY; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned an adult female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid in JAN-2021. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 26-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On unspecified date in 01-JUL-2021, patient had COVID-19 antibody test, and it was positive 86.9 and patient was wondered why she was being mandated to get the vaccine. On 26-AUG-2021, the patient experienced blood in stool, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), shakiness, brain fog, neck pain, injection site reaction, diarrhea, arms feel heavy, headache, and fatigued. On an unspecified date in AUG-2021, The patient went to the hospital for evaluation due to the bloody stool and kidney pain, and had computerised tomogram (CAT) scan done. The patient reported that as per health care provider (HCP), the CAT scan was clear and it was from the shot.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness, blood in stool, diarrhea, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), neck pain, headache, brain fog, injection site reaction, fatigued, and arms feel heavy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210858571-Covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor, Urinary tract infection
Clinical narrative: BLOOD IN STOOL; SHAKINESS; URINARY TRACT INFECTION (UTI) SYMPTOMS SUCH AS SEDIMENT IN URINE; BRAIN FOG; NECK PAIN; INJECTION SITE REACTION; DIARRHEA; ARMS FEEL HEAVY; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned an adult female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid in JAN-2021. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 26-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On unspecified date in 01-JUL-2021, patient had COVID-19 antibody test, and it was positive 86.9 and patient was wondered why she was being mandated to get the vaccine. On 26-AUG-2021, the patient experienced blood in stool, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), shakiness, brain fog, neck pain, injection site reaction, diarrhea, arms feel heavy, headache, and fatigued. On an unspecified date in AUG-2021, The patient went to the hospital for evaluation due to the bloody stool and kidney pain, and had computerised tomogram (CAT) scan done. The patient reported that as per health care provider (HCP), the CAT scan was clear and it was from the shot.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness, blood in stool, diarrhea, urinary tract infection (UTI) symptoms such as sediment in urine (kidney pain, back pain, fever), neck pain, headache, brain fog, injection site reaction, fatigued, and arms feel heavy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210858571-Covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF protein increased, CSF white blood cell count increased, Dissociation, Facial paresis, Guillain-Barre syndrome
Clinical narrative: The pain started in both feet in a course of the week it move up his entire body .After two ER visits and One Urgent care we ask for a spinal test with results positive Guillian Barre.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Lumbar puncture abnormal, Paraesthesia
Clinical narrative: The pain started in both feet in a course of the week it move up his entire body .After two ER visits and One Urgent care we ask for a spinal test with results positive Guillian Barre.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Guillain-Barre syndrome, Laboratory test normal, Lumbar puncture abnormal, Pain
Clinical narrative: The pain started in both feet in a course of the week it move up his entire body .After two ER visits and One Urgent care we ask for a spinal test with results positive Guillian Barre.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: The pain started in both feet in a course of the week it move up his entire body .After two ER visits and One Urgent care we ask for a spinal test with results positive Guillian Barre.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: Patient returned to pharmacy to notify that he is still having joint pain that still persists on and off,  which started after receiving the J/J covid-19 vaccination. He also continue to have arm pain on the  arm he received the vaccine at. He has followed up with his MD and he had done labwork and  evaluated the patient's condition. Md advised that patient return to pharmacy to report persistant side effects.